Jacob George
Biographic Data
| ID | 3800433 |
|---|---|
| NAME | Jacob George |
| GIVEN NAMES | Jacob |
| FAMILY NAME | George |
| SIGNATURE | GEORGE J |
| AFFILIATIONS | The University of Sydney |
| ORCID | 0000-0002-8421-5476 |
| VERIFIED | Yes |
| TOTAL WORKS | 9 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 9 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2017 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Trends in cause-specific mortality among people with hepatitis C virus in New South Wales, Australia
During the HCV elimination era, both liver-related and drug-related mortality have declined, suggesting direct and indirect impacts of DAA therapy, respectively. Expanded opioid agonist therapy coverage and enhanced alcohol use disorder management could further reduce mortality
Alcohol does not impact chronic hepatitis C treatment outcomes but increases risk for progressive liver disease
Factors associated with hepatitis C treatment uptake among females of childbearing age in New South Wales, Australia
Micro‐elimination of chronic hepatitis C virus in mental health settings
Demographic, health, and prognostic characteristics of Australians with liver cancer
Linked data enabled more detailed risk profiling than previously possible. This will support the targeting of cancer services and benchmarking
Client resistance to hepatitis C treatment initiation in opioid agonist treatment clinics in Sydney, Australia
Hepatitis B and Liver Cancer
Chronic hepatitis B (CHB) is a significant global health challenge given an increasing morbidity and inadequate public health response, Migrant populations are primarily affected by CHB in industrialised countries, and while more than 7% of Australians with CHB were born in Africa or the Middle East, little is known of their awareness or knowledge of viral hepatitis and its impact. This qualitative study, using semi-structured interviews with Ass…
Listening to both sides
This qualitative study compares and contrasts the perspectives of healthcare professionals who treat hepatitis C with those of patients in treatment. Comparative analysis of semi-structured interviews with 20 healthcare professionals and 20 patients undergoing treatment for hepatitis C concluded that patients and healthcare professionals disagreed on the source of communication breakdowns, but both felt that individualised clinical information im…
Listening to the consumer voice
BACKGROUND: In Australia, liver cancer incidence is rising, particularly among people born in hepatitis B-endemic countries. We sought to build an understanding of the information needs of people affected by liver cancer, to inform the design of in-language consumer information resources. METHODS: We searched the World Wide Web for available in-language consumer information and conducted a literature search on consumers' information needs and the…
No prominent works on this page.
Listening to the consumer voice
BACKGROUND: In Australia, liver cancer incidence is rising, particularly among people born in hepatitis B-endemic countries. We sought to build an understanding of the information needs of people affected by liver cancer, to inform the design of in-language consumer information resources. METHODS: We searched the World Wide Web for available in-language consumer information and conducted a literature search on consumers' information needs and the…
Listening to both sides
This qualitative study compares and contrasts the perspectives of healthcare professionals who treat hepatitis C with those of patients in treatment. Comparative analysis of semi-structured interviews with 20 healthcare professionals and 20 patients undergoing treatment for hepatitis C concluded that patients and healthcare professionals disagreed on the source of communication breakdowns, but both felt that individualised clinical information im…
Hepatitis B and Liver Cancer
Chronic hepatitis B (CHB) is a significant global health challenge given an increasing morbidity and inadequate public health response, Migrant populations are primarily affected by CHB in industrialised countries, and while more than 7% of Australians with CHB were born in Africa or the Middle East, little is known of their awareness or knowledge of viral hepatitis and its impact. This qualitative study, using semi-structured interviews with Ass…
Client resistance to hepatitis C treatment initiation in opioid agonist treatment clinics in Sydney, Australia
Demographic, health, and prognostic characteristics of Australians with liver cancer
Linked data enabled more detailed risk profiling than previously possible. This will support the targeting of cancer services and benchmarking
Alcohol does not impact chronic hepatitis C treatment outcomes but increases risk for progressive liver disease
Factors associated with hepatitis C treatment uptake among females of childbearing age in New South Wales, Australia
Micro‐elimination of chronic hepatitis C virus in mental health settings
Trends in cause-specific mortality among people with hepatitis C virus in New South Wales, Australia
During the HCV elimination era, both liver-related and drug-related mortality have declined, suggesting direct and indirect impacts of DAA therapy, respectively. Expanded opioid agonist therapy coverage and enhanced alcohol use disorder management could further reduce mortality
Medicine (9 works) · Hepatitis C virus research (7 works) · Internal Medicine (7 works) · Hepatitis C (5 works) · Family medicine (4 works) · Demography (3 works) · Diabetes Management and Education (3 works) · Liver Disease Diagnosis and Treatment (3 works) · Psychology (3 works) · Active listening (2 works)